OBIO
Orchestra BioMed Holdings, Inc.
Company overview
- Market capitalization
- $354.02M
- Employees
- 86
- Latest publication
- 2026-09-29
About Orchestra BioMed Holdings, Inc.
Orchestra BioMed Holdings, Inc. operates as a biomedical company in the United States. The company's flagship product candidates include Atrioventricular Interval Modulation, a bioelectronic therapy candidate designed to immediately, substantially, and persistently lower blood pressure; and Virtue Sirolimus AngioInfusion Balloon for the treatment of atherosclerotic artery disease. It also develops Cardiac Neuromodulation Therapy for heart failure, or potential treatment of clinical indications, such as urology or osteoarthritis; and CNT-HF, a bioelectronic product candidate that aims to reduce chronic sympathetic nervous system activity in heart failure. In addition, the company offers FreeHold devices and additional minimally invasive surgery enabling devices; and Pure-Vu system, a medical device to facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and upper gastrointestinal endoscopy procedures. It has a collaboration agreement with Medtronic, Inc. for the development of AVIM therapy for the treatment of HTN in pacemaker-indicated patients; and a strategic collaboration with Terumo Corporation and Terumo Medical Corporation for the development and commercialization of Virtue SAB for the treatment of coronary and peripheral vascular disease. Orchestra BioMed Holdings, Inc. was founded in 2018 and is headquartered in New Hope, Pennsylvania.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 110,000USD | 30,917,000USD | 861,000USD | 836,000USD | 868,000USD | 253,000USD | 987,000USD | 778,000USD |
| Cost Of Revenue | 92,000USD | 51,000USD | 49,000USD | 46,000USD | 44,000USD | 58,000USD | 68,000USD | 44,000USD |
| Gross Profit | 18,000USD | 30,866,000USD | 812,000USD | 790,000USD | 824,000USD | 195,000USD | 919,000USD | 734,000USD |
| Research Development | 15,781,000USD | 16,823,000USD | 14,027,000USD | 13,853,000USD | 13,482,000USD | 10,971,000USD | 11,595,000USD | 11,126,000USD |
| Selling General Administrative | 6,373,000USD | 7,289,000USD | 7,098,000USD | 6,264,000USD | 6,263,000USD | 5,901,000USD | 5,666,000USD | 6,467,000USD |
| Total Operating Expenses | 22,094,000USD | 24,112,000USD | 21,125,000USD | 20,117,000USD | 19,745,000USD | 16,872,000USD | 17,261,000USD | 17,593,000USD |
| Operating Income | -22,076,000USD | 6,754,000USD | -20,313,000USD | -19,327,000USD | -18,921,000USD | -16,677,000USD | -16,342,000USD | -16,859,000USD |
| Interest Expense | 821,000USD | 763,000USD | 515,000USD | 36,000USD | — | — | — | — |
| Net Interest Income | -821,000USD | -763,000USD | -515,000USD | -36,000USD | 166,000USD | 522,000USD | 916,000USD | 902,000USD |
| Income Before Tax | -20,691,000USD | 6,245,000USD | -20,828,000USD | -19,363,000USD | -18,755,000USD | -16,155,000USD | -15,426,000USD | -15,980,000USD |
| Net Income | -20,691,000USD | 6,245,000USD | -20,828,000USD | -19,363,000USD | -18,755,000USD | -16,155,000USD | -15,426,000USD | -15,980,000USD |
| Net Income From Continuing Ops | -20,691,000USD | 6,245,000USD | -20,828,000USD | -19,363,000USD | -18,755,000USD | -16,155,000USD | -15,426,000USD | -15,980,000USD |
| Ebit | -22,076,000USD | 7,008,000USD | -20,313,000USD | -19,327,000USD | -18,921,000USD | -16,677,000USD | -16,342,000USD | -16,859,000USD |
| Ebitda | -21,986,000USD | 7,090,000USD | -20,232,000USD | -19,246,000USD | -18,838,000USD | -16,593,000USD | -16,266,000USD | -16,785,000USD |
| Depreciation And Amortization | 90,000USD | 82,000USD | 81,000USD | 81,000USD | 83,000USD | 84,000USD | 76,000USD | 74,000USD |
| Reconciled Depreciation | 90,000USD | 82,000USD | 81,000USD | 81,000USD | 83,000USD | 84,000USD | 76,000USD | 74,000USD |
| Total Other Income Expense Net | 1,385,000USD | -509,000USD | -515,000USD | -36,000USD | 166,000USD | 522,000USD | 916,000USD | 879,000USD |
| Interest Income | — | — | — | — | 166,000USD | 522,000USD | 916,000USD | 902,000USD |
| Income Tax Expense | — | — | — | — | — | -30,724USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Revenue | 33,482,000USD | 2,638,000USD | 2,760,000USD | 3,533,000USD | -782,000USD | 5,703,000USD |
| Cost Of Revenue | 190,000USD | 204,000USD | 186,000USD | 322,000USD | 199,000USD | 145,000USD |
| Gross Profit | 33,292,000USD | 2,434,000USD | 2,574,000USD | 3,211,000USD | -981,000USD | 5,558,000USD |
| Research Development | 58,185,000USD | 42,804,000USD | 33,822,000USD | 21,945,000USD | 12,890,000USD | 13,477,000USD |
| Selling General Administrative | 26,914,000USD | 23,931,000USD | 20,258,000USD | 14,034,000USD | 7,928,000USD | 10,833,000USD |
| Total Operating Expenses | 85,099,000USD | 66,735,000USD | 54,080,000USD | 35,868,000USD | 20,818,000USD | 24,310,000USD |
| Operating Income | -51,807,000USD | -64,301,000USD | -51,506,000USD | -32,657,000USD | -21,799,000USD | -18,752,000USD |
| Interest Expense | 1,148,000USD | — | — | — | 927,000USD | — |
| Net Interest Income | -1,148,000USD | 3,356,000USD | 3,849,000USD | 50,000USD | -927,000USD | 331,000USD |
| Income Before Tax | -52,701,000USD | -61,024,000USD | -49,120,000USD | -33,608,000USD | -23,014,000USD | -21,355,000USD |
| Net Income | -52,701,000USD | -61,024,000USD | -49,120,000USD | -33,608,000USD | -23,014,000USD | -21,355,000USD |
| Net Income From Continuing Ops | -52,701,000USD | -61,024,000USD | -49,120,000USD | -33,608,000USD | -23,014,000USD | -21,355,000USD |
| Ebit | -51,553,000USD | -64,301,000USD | -51,506,000USD | -32,657,000USD | -21,799,000USD | -18,752,000USD |
| Ebitda | -51,226,000USD | -63,993,000USD | -51,219,000USD | -32,435,000USD | -21,618,000USD | -18,615,000USD |
| Depreciation And Amortization | 327,000USD | 308,000USD | 287,000USD | 222,000USD | 181,000USD | 137,000USD |
| Reconciled Depreciation | 327,000USD | 308,000USD | 287,000USD | 222,000USD | 181,000USD | 137,000USD |
| Total Other Income Expense Net | -894,000USD | 3,277,000USD | 2,386,000USD | -951,000USD | -1,215,000USD | -2,603,000USD |
| Interest Income | — | 3,356,000USD | 3,849,000USD | 50,000USD | — | 331,000USD |
| Income Tax Expense | — | — | 119,105USD | -222,000USD | 927,000USD | 2,603,000USD |
| Net Income Applicable To Common Shares | — | — | — | — | -23,014,000USD | -21,355,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 100,658,000USD | 114,857,000USD | 104,807,000USD | 42,825,000USD | 59,051,000USD | 76,173,000USD | 75,319,000USD | 72,383,000USD |
| Other Current Assets | 1,448,000USD | 994,000USD | 1,531,000USD | 1,690,000USD | 1,795,000USD | 2,094,000USD | 1,278,000USD | 1,150,000USD |
| Total Liab | 49,693,000USD | 51,479,000USD | 61,068,000USD | 42,530,000USD | 42,194,000USD | 43,215,000USD | 29,100,000USD | 28,258,000USD |
| Total Stockholder Equity | 50,965,000USD | 63,378,000USD | 43,739,000USD | 295,000USD | 16,857,000USD | 32,958,000USD | 46,219,000USD | 44,125,000USD |
| Other Current Liab | 6,594,000USD | 9,890,000USD | 6,837,000USD | 6,650,000USD | 5,392,000USD | 6,084,000USD | 7,034,000USD | 4,225,000USD |
| Common Stock | 6,000USD | 6,000USD | 6,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD |
| Capital Stock | 6,000USD | 6,000USD | 6,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD | 4,000USD |
| Retained Earnings | -383,270,000USD | -362,579,000USD | -368,824,000USD | -347,996,000USD | -328,633,000USD | -309,878,000USD | -293,723,000USD | -278,297,000USD |
| Other Assets | 1USD | — | — | — | — | — | — | 1USD |
| Cash | 28,367,000USD | 34,690,000USD | 42,012,000USD | 18,749,000USD | 18,348,000USD | 22,261,000USD | 25,605,000USD | 23,713,000USD |
| Cash And Short Term Investments | 94,400,000USD | 106,512,000USD | 95,820,000USD | 33,924,000USD | 49,884,000USD | 66,812,000USD | 66,926,000USD | 65,181,000USD |
| Total Current Assets | 96,209,000USD | 107,911,000USD | 97,768,000USD | 35,882,000USD | 51,903,000USD | 69,171,000USD | 68,553,000USD | 66,481,000USD |
| Total Current Liabilities | 13,692,000USD | 16,736,000USD | 20,655,000USD | 17,061,000USD | 15,489,000USD | 16,207,000USD | 16,218,000USD | 14,504,000USD |
| Net Debt | 5,268,000USD | -2,253,000USD | -25,977,000USD | -2,395,000USD | -1,904,000USD | -5,732,000USD | -23,767,000USD | -22,261,000USD |
| Short Term Debt | 785,000USD | 751,000USD | 696,000USD | 642,000USD | 590,000USD | 550,000USD | 395,000USD | 350,000USD |
| Short Long Term Debt Total | 33,635,000USD | 32,437,000USD | 16,035,000USD | 16,354,000USD | 16,444,000USD | 16,529,000USD | 1,838,000USD | 1,452,000USD |
| Long Term Debt | 14,333,000USD | 14,268,000USD | 14,204,000USD | 14,384,000USD | 14,338,000USD | 14,292,000USD | — | — |
| Long Term Investments | 0USD | 2,495,000USD | 2,495,000USD | 2,495,000USD | 2,495,000USD | 2,495,000USD | 2,495,000USD | 2,495,000USD |
| Short Term Investments | 66,033,000USD | 71,822,000USD | 53,808,000USD | 15,175,000USD | 31,536,000USD | 44,551,000USD | 41,321,000USD | 41,468,000USD |
| Net Receivables | 84,000USD | 95,000USD | 52,000USD | 83,000USD | 89,000USD | 92,000USD | 115,000USD | 80,000USD |
| Inventory | 277,000USD | 310,000USD | 365,000USD | 185,000USD | 135,000USD | 173,000USD | 234,000USD | 70,000USD |
| Accounts Payable | 6,313,000USD | 6,095,000USD | 8,473,000USD | 5,308,000USD | 5,563,000USD | 5,134,000USD | 4,723,000USD | 6,273,000USD |
| Property Plant Equipment Net | 3,185,000USD | 3,211,000USD | 3,248,000USD | 3,172,000USD | 3,369,000USD | 3,487,000USD | 2,968,000USD | 2,566,000USD |
| Property Plant Equipment Gross | 4,906,000USD | 4,842,000USD | 4,796,000USD | 4,639,000USD | 4,755,000USD | 4,790,000USD | 4,187,000USD | 3,710,000USD |
| Accumulated Other Comprehensive Income | -40,000USD | 60,000USD | 45,000USD | 16,000USD | 37,000USD | 52,000USD | 98,000USD | -23,000USD |
| Common Stock Shares Outstanding | 38,392,716shares | 38,392,716shares | 38,392,716shares | 38,392,716shares | 38,235,409shares | 38,064,263shares | 37,621,495shares | 35,800,273shares |
| Non Current Assets Total | 4,448,999USD | 6,946,000USD | 7,039,000USD | 6,943,000USD | 7,148,000USD | 7,002,000USD | 6,766,000USD | 5,902,000USD |
| Non Current Liabilities Total | 36,001,000USD | 34,743,000USD | 40,413,000USD | 25,469,000USD | 26,705,000USD | 27,008,000USD | 12,882,000USD | 13,754,000USD |
| Non Current Liabilities Other | 18,154,000USD | 16,790,000USD | 16,415,000USD | 189,000USD | 99,000USD | 40,000USD | — | — |
| Non Currrent Assets Other | 1,263,999USD | 1,240,000USD | 1,296,000USD | 1,276,000USD | 1,284,000USD | 1,020,000USD | 1,303,000USD | 841,000USD |
| Net Working Capital | 82,517,000USD | 91,175,000USD | 77,113,000USD | 18,821,000USD | 36,414,000USD | 52,964,000USD | 52,335,000USD | 51,977,000USD |
| Unclassified Non Current Liabilities | 3,514,000USD | 3,685,000USD | 9,794,000USD | 10,896,000USD | 12,268,000USD | 12,676,000USD | 12,882,000USD | 13,754,000USD |
| Unclassified Equity | 434,263,000USD | 425,885,000USD | 412,506,000USD | 348,267,000USD | 345,445,000USD | 342,776,000USD | 339,836,000USD | 322,437,000USD |
| Current Deferred Revenue | — | — | 4,649,000USD | 4,461,000USD | 3,944,000USD | 4,439,000USD | 4,066,000USD | 3,656,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Assets | 114,857,000USD | 76,173,000USD | 95,212,000USD | 95,572,000USD | 13,527,000USD | 38,092,000USD |
| Other Current Assets | 994,000USD | 2,094,000USD | 1,274,000USD | 533,000USD | 234,000USD | 227,000USD |
| Total Liab | 51,479,000USD | 43,215,000USD | 27,169,000USD | 43,038,000USD | 84,759,000USD | 86,634,000USD |
| Total Stockholder Equity | 63,378,000USD | 32,958,000USD | 68,043,000USD | 52,534,000USD | -71,232,000USD | -48,542,000USD |
| Other Current Liab | 9,890,000USD | 6,084,000USD | 5,149,000USD | 7,465,000USD | 2,668,000USD | 2,718,000USD |
| Common Stock | 6,000USD | 4,000USD | 4,000USD | 2,000USD | 160,000,445USD | 160,000,445USD |
| Capital Stock | 6,000USD | 4,000USD | 4,000USD | 2,000USD | 0USD | 0USD |
| Retained Earnings | -362,579,000USD | -309,878,000USD | -248,854,000USD | -199,734,000USD | -166,126,000USD | -143,112,000USD |
| Cash | 34,690,000USD | 22,261,000USD | 30,559,000USD | 19,784,000USD | 9,938,000USD | 20,343,000USD |
| Cash And Short Term Investments | 106,512,000USD | 66,812,000USD | 87,595,000USD | 83,785,000USD | 10,896,000USD | 35,790,000USD |
| Total Current Assets | 107,911,000USD | 69,171,000USD | 89,114,000USD | 84,690,000USD | 11,319,000USD | 36,254,000USD |
| Total Current Liabilities | 16,736,000USD | 16,207,000USD | 11,208,000USD | 18,566,000USD | 12,240,000USD | 14,362,000USD |
| Net Debt | -33,003,000USD | -5,732,000USD | -28,872,000USD | -7,914,000USD | -4,265,000USD | -10,887,000USD |
| Short Term Debt | 751,000USD | 550,000USD | 649,000USD | 697,000USD | 2,000,000USD | 4,000,000USD |
| Short Long Term Debt Total | 1,687,000USD | 16,529,000USD | 1,687,000USD | 11,870,000USD | 5,673,000USD | 9,456,000USD |
| Long Term Debt | 14,268,000USD | 14,292,000USD | — | 9,490,000USD | 3,673,000USD | 5,456,000USD |
| Long Term Investments | 2,495,000USD | 2,495,000USD | 2,495,000USD | 2,495,000USD | 398,000USD | 185,000USD |
| Short Term Investments | 71,822,000USD | 44,551,000USD | 57,036,000USD | 64,001,000USD | 958,000USD | 15,447,000USD |
| Net Receivables | 95,000USD | 92,000USD | 99,000USD | 96,000USD | 121,000USD | 168,000USD |
| Inventory | 310,000USD | 173,000USD | 146,000USD | 276,000USD | 68,000USD | 69,000USD |
| Accounts Payable | 6,095,000USD | 5,134,000USD | 2,900,000USD | 3,968,000USD | 2,029,000USD | 1,774,000USD |
| Property Plant Equipment Net | 3,211,000USD | 3,487,000USD | 2,834,000USD | 3,676,000USD | 1,120,000USD | 1,027,000USD |
| Property Plant Equipment Gross | 4,842,000USD | 4,790,000USD | 3,878,000USD | 4,454,000USD | 1,705,000USD | 1,444,000USD |
| Accumulated Other Comprehensive Income | 60,000USD | 52,000USD | -10,000USD | -8,000USD | -211,452,445USD | -2,000USD |
| Common Stock Shares Outstanding | 38,392,716shares | 36,821,042shares | 33,225,226shares | 25,472,441shares | 20,450,000shares | 20,450,000shares |
| Non Current Assets Total | 6,946,000USD | 7,002,000USD | 6,098,000USD | 10,882,000USD | 2,208,000USD | 1,838,000USD |
| Non Current Liabilities Total | 34,743,000USD | 27,008,000USD | 15,961,000USD | 24,472,000USD | 72,519,000USD | 72,272,000USD |
| Non Current Liabilities Other | 16,790,000USD | 40,000USD | — | 196,000USD | 535,000USD | 241,000USD |
| Non Currrent Assets Other | 1,240,000USD | 1,020,000USD | 769,000USD | 4,711,000USD | 690,000USD | 626,000USD |
| Net Working Capital | 91,175,000USD | 52,964,000USD | 77,906,000USD | 66,124,000USD | -921,000USD | 21,892,000USD |
| Unclassified Non Current Liabilities | 3,685,000USD | 12,676,000USD | 15,961,000USD | 14,786,000USD | 50,817,000USD | 51,211,000USD |
| Unclassified Equity | 425,885,000USD | 342,776,000USD | 316,899,000USD | 252,272,000USD | 146,346,000USD | -65,428,445USD |
| Current Deferred Revenue | — | 4,439,000USD | 2,510,000USD | 6,436,000USD | 5,542,000USD | 5,803,000USD |
| Other Assets | — | — | 1USD | 1USD | 690,000USD | 626,000USD |
| Deferred Long Term Liab | — | — | — | — | 100,000USD | — |
| Other Liab | — | — | — | — | 17,394,000USD | 15,364,000USD |
| Short Long Term Debt | — | — | — | — | 2,000,000USD | 4,000,000USD |
| Net Tangible Assets | — | — | — | — | -71,232,000USD | -48,542,000USD |
| Unclassified Current Liabilities | — | — | — | — | -1,999,000USD | -3,933,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -20,691,000USD | 6,245,000USD | -20,828,000USD | -19,363,000USD | -18,755,000USD | -16,155,000USD | -15,426,000USD | -15,980,000USD |
| Depreciation | 90,000USD | 82,000USD | 81,000USD | 81,000USD | 83,000USD | 84,000USD | 76,000USD | 74,000USD |
| Stock Based Compensation | 2,851,000USD | 2,750,000USD | 3,013,000USD | 3,250,000USD | 2,965,000USD | 2,902,000USD | 2,364,000USD | 2,761,000USD |
| Other Non Cash Items | 2,096,000USD | 934,000USD | 643,000USD | 147,000USD | 81,000USD | 994,000USD | 523,000USD | -132,000USD |
| Change To Account Receivables | 11,000USD | -43,000USD | 31,000USD | 6,000USD | 3,000USD | 38,000USD | -35,000USD | -13,000USD |
| Change To Inventory | 33,000USD | 55,000USD | -181,000USD | -49,000USD | 38,000USD | 60,000USD | -164,000USD | 45,000USD |
| Change In Working Capital | -3,663,000USD | -12,281,000USD | 2,541,000USD | 358,000USD | -990,000USD | -1,363,000USD | -1,237,000USD | 3,071,000USD |
| Total Cash From Operating Activities | -22,168,000USD | -2,270,000USD | -14,550,000USD | -15,527,000USD | -16,616,000USD | -13,538,000USD | -13,700,000USD | -10,206,000USD |
| Capital Expenditures | -184,000USD | -33,000USD | -310,000USD | -34,000USD | -112,000USD | -106,000USD | -68,000USD | -107,000USD |
| Free Cash Flow | -22,352,000USD | -2,303,000USD | -14,860,000USD | -15,561,000USD | -16,728,000USD | -13,644,000USD | -13,768,000USD | -10,313,000USD |
| Investments | 10,502,000USD | -17,679,000USD | -38,584,000USD | 16,356,000USD | 12,999,000USD | -3,753,000USD | 557,000USD | 10,424,000USD |
| Total Cashflows From Investing Activities | 10,318,000USD | -17,712,000USD | -38,584,000USD | 16,356,000USD | 12,999,000USD | -3,753,000USD | 557,000USD | 10,424,000USD |
| Total Cash From Financing Activities | 5,527,000USD | 12,660,000USD | 76,397,000USD | -428,000USD | -296,000USD | 13,947,000USD | 15,035,000USD | 171,000USD |
| Issuance Of Capital Stock | 5,855,000USD | 14,100,000USD | — | — | 0USD | 0USD | — | — |
| Change In Cash | -6,323,000USD | -7,322,000USD | 23,263,000USD | 401,000USD | -3,913,000USD | -3,344,000USD | 1,892,000USD | 389,000USD |
| Begin Period Cash Flow | 34,690,000USD | 42,012,000USD | 18,749,000USD | 18,348,000USD | 22,261,000USD | 25,605,000USD | 23,713,000USD | 23,324,000USD |
| End Period Cash Flow | 28,367,000USD | 34,690,000USD | 42,012,000USD | 18,749,000USD | 18,348,000USD | 22,261,000USD | 25,605,000USD | 23,713,000USD |
| Other Cashflows From Investing Activities | 2,241,000USD | — | — | — | — | -602,000USD | — | — |
| Other Cashflows From Financing Activities | -354,000USD | -468,000USD | -269,000USD | -428,000USD | -387,000USD | -1,104,000USD | 15,035,000USD | 171,000USD |
| Unclassified Operating Cash Flow | -2,851,000USD | — | — | — | — | — | — | — |
| Unclassified Investing Cash Flow | -2,241,000USD | — | — | — | — | — | — | — |
| Unclassified Financing Cash Flow | — | — | 76,666,000USD | — | — | 15,051,000USD | — | — |
| Sale Purchase Of Stock | — | — | — | -428,000USD | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Net Income | -52,701,000USD | -61,024,000USD | -49,120,000USD | -33,608,000USD | -23,014,000USD | -21,355,000USD |
| Depreciation | 327,000USD | 308,000USD | 287,000USD | 222,000USD | 181,000USD | 137,000USD |
| Stock Based Compensation | 11,978,000USD | 10,615,000USD | 7,625,000USD | 3,413,000USD | 302,000USD | 221,000USD |
| Other Non Cash Items | 1,805,000USD | 308,000USD | -1,612,000USD | 1,135,000USD | 217,000USD | 2,934,000USD |
| Change To Account Receivables | -3,000USD | 22,000USD | -3,000USD | 25,000USD | 47,000USD | -79,000USD |
| Change To Inventory | -137,000USD | -28,000USD | 131,000USD | -208,000USD | 1,000USD | -26,000USD |
| Change In Working Capital | -10,372,000USD | -765,000USD | -3,307,000USD | -451,000USD | 2,597,000USD | -8,120,000USD |
| Total Cash From Operating Activities | -48,963,000USD | -50,558,000USD | -46,127,000USD | -29,289,000USD | -19,429,000USD | -26,183,000USD |
| Capital Expenditures | -489,000USD | -289,000USD | -78,000USD | -591,000USD | -274,000USD | -539,000USD |
| Free Cash Flow | -49,452,000USD | -50,847,000USD | -46,205,000USD | -29,880,000USD | -19,703,000USD | -26,722,000USD |
| Investments | -26,452,000USD | 13,089,000USD | 10,687,000USD | -64,122,000USD | 13,017,000USD | 26,966,000USD |
| Total Cashflows From Investing Activities | -26,941,000USD | 13,089,000USD | 10,687,000USD | -64,122,000USD | 13,017,000USD | 26,966,000USD |
| Net Borrowings | 0USD | 15,000,000USD | -10,849,000USD | 3,554,000USD | -4,000,000USD | 10,000,000USD |
| Total Cash From Financing Activities | 88,333,000USD | 29,171,000USD | 46,215,000USD | 103,257,000USD | -3,993,000USD | 10,000,000USD |
| Issuance Of Capital Stock | 71,880,000USD | 15,035,000USD | 0USD | 109,830,000USD | — | — |
| Change In Cash | 12,429,000USD | -8,298,000USD | 10,775,000USD | 9,846,000USD | -10,405,000USD | 10,783,000USD |
| Begin Period Cash Flow | 22,261,000USD | 30,559,000USD | 19,784,000USD | 9,938,000USD | 20,343,000USD | 9,560,000USD |
| End Period Cash Flow | 34,690,000USD | 22,261,000USD | 30,559,000USD | 19,784,000USD | 9,938,000USD | 20,343,000USD |
| Other Cashflows From Financing Activities | -1,552,000USD | -864,000USD | 56,810,000USD | -10,127,000USD | 7,000USD | -162,285,330USD |
| Unclassified Financing Cash Flow | 18,005,000USD | — | — | 202,421,090USD | — | 162,285,330USD |
| Other Cashflows From Investing Activities | — | -602,000USD | — | -63,531,000USD | 13,291,000USD | 27,505,000USD |
| Sale Purchase Of Stock | — | — | — | -92,591,090USD | — | — |
| Unclassified Investing Cash Flow | — | — | — | 64,122,000USD | -13,017,000USD | -26,966,000USD |
| Change To Liabilities | — | — | — | — | 2,553,000USD | -7,776,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
| Period | Dimension | Business / region | Revenue | Currency | Source |
|---|---|---|---|---|---|
| FY 2025Yearly · 2025-12-31 | Product | Partnership Revenue | 32,871,000 | USD | 0001104659-26-026754 |
| FY 2025Yearly · 2025-12-31 | Product | Product | 611,000 | USD | 0001104659-26-026754 |
| Q4 2025Quarterly · 2025-12-31 | Product | Partnership Revenue | 30,751,000 | USD | Legacy provider |
| Q4 2025Quarterly · 2025-12-31 | Product | Product | 166,000 | USD | Legacy provider |
| Q3 2025Quarterly · 2025-09-30 | Product | Partnership Revenue | 721,000 | USD | 0001104659-25-109128 |
| Q3 2025Quarterly · 2025-09-30 | Product | Product | 140,000 | USD | 0001104659-25-109128 |
| Q2 2025Quarterly · 2025-06-30 | Product | Partnership Revenue | 667,000 | USD | 0001558370-25-011148 |
| Q2 2025Quarterly · 2025-06-30 | Product | Product | 169,000 | USD | 0001558370-25-011148 |
| Q1 2025Quarterly · 2025-03-31 | Product | Partnership Revenue | 732,000 | USD | 0001104659-26-059382 |
| Q1 2025Quarterly · 2025-03-31 | Product | Product | 136,000 | USD | 0001104659-26-059382 |
| FY 2024Yearly · 2024-12-31 | Product | Partnership Revenue | 2,005,000 | USD | 0001104659-26-026754 |
| FY 2024Yearly · 2024-12-31 | Product | Product | 633,000 | USD | 0001104659-26-026754 |
| Q4 2024Quarterly · 2024-12-31 | Product | Partnership Revenue | 77,000 | USD | Legacy provider |
| Q4 2024Quarterly · 2024-12-31 | Product | Product | 176,000 | USD | Legacy provider |
| Q3 2024Quarterly · 2024-09-30 | Product | Partnership Revenue | 803,000 | USD | 0001104659-25-109128 |
| Q3 2024Quarterly · 2024-09-30 | Product | Product | 184,000 | USD | 0001104659-25-109128 |
| Q2 2024Quarterly · 2024-06-30 | Product | Partnership Revenue | 628,000 | USD | 0001558370-25-011148 |
| Q2 2024Quarterly · 2024-06-30 | Product | Product | 150,000 | USD | 0001558370-25-011148 |
| Q1 2024Quarterly · 2024-03-31 | Product | Partnership Revenue | 497,000 | USD | 0001558370-25-007373 |
| Q1 2024Quarterly · 2024-03-31 | Product | Product | 123,000 | USD | 0001558370-25-007373 |
| FY 2023Yearly · 2023-12-31 | Product | Partnership Revenue | 2,106,000 | USD | 0001558370-25-004161 |
| FY 2023Yearly · 2023-12-31 | Product | Product | 654,000 | USD | 0001558370-25-004161 |
| FY 2022Yearly · 2022-12-31 | Product | Partnership Revenue | 2,862,000 | USD | 0001558370-24-004083 |
| FY 2022Yearly · 2022-12-31 | Product | Product | 671,000 | USD | 0001558370-24-004083 |
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.